| Detected | Trial | Change |
|---|---|---|
| 2026-05-28 | NCT05562830 A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1)… |
date change Primary completion moved earlier: 2030-06-28 -> 2029-02-26 |
| 2026-05-28 | NCT05562830 A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1)… |
date change Completion moved earlier: 2030-06-28 -> 2029-02-26 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT07222488 | A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) | Bladder Cancer | Recruiting |
| NCT07232602 | KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab… | Bladder Cancer | Recruiting |
| NCT06818643 | A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced… | Advanced Solid Tumors | Recruiting |
| NCT05562830 | A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1)… | Urothelial Carcinoma | Recruiting |